N/A
N=97
Text4Father Pilot Feasibility, Acceptability Study
Fathers · Mhealth · Mobile Health · Nuclear Family
Bottom Line
View on ClinicalTrials.gov: NCT04101565 ↗Enrolled (actual)
97
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Feasibility of Overall Recruitment — 53; 44 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Text4Father (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Johns Hopkins University
- Primary completion
- May 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Feasibility of Overall Recruitment |
53; 44 | — |
| PRIMARY Feasibility of Overall Retention |
41; 34 | — |
| PRIMARY Intervention Usability as Assessed by the Usability Score |
3.38 | — |
| PRIMARY Intervention Acceptability as Assessed by the Acceptability Score |
3.33 | — |
| SECONDARY Self-efficacy as Assessed by the Parenting Sense of Competence Scale (PSOC) |
4.49; 4.49 | — |
Summary
This study evaluates the feasibility, acceptability, and preliminary efficacy of Text4Father among first-time lower income fathers. Half of the participants will receive Text4Father - a text messaging educational program - from mid-pregnancy through 2 months of postnatal age, while the other half will receive usual care.
Eligibility Criteria
Inclusion Criteria
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Self-reported expectant father and pregnant partner (expectant mother)
- Aged ≥18 years
- In a romantic relationship and expect to continue to be in this relationship during the study period
- Able to speak English
- Lower socioeconomic status (SES) (e.g., high school/general education or vocational/trade school or less; or qualify for Medicaid/public insurance, WIC, SNAP, food stamps)
- Access to necessary resources for participating in a technology-based intervention (i.e., cell phone) and willing/able to receive/send texts
Exclusion Criteria
- Individuals who are not able to provide informed consent.
Data sourced from ClinicalTrials.gov (NCT04101565). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.